{
  "id": 4878552,
  "title": "Roche taps Simcere for trispecific T cell engager pact with $75M upfront",
  "url": "https://urgent.news/2026/09/01/roche-taps-simcere-for-trispecific-t-cell-engager-pact-with-75m",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-01T14:40:27.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/roche-taps-simcere-for-trispecific-t-cell-engager-pact-with-75m-upfront/"
  },
  "original_language": "en",
  "account": null,
  "summary": "For the second time in as many weeks, Roche's business development team has lined up a deal with a Chinese biopharma. The Swiss drug giant this time is teaming with Simcere Zaiming on a preclinical ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}